Everett and Hurite Ophthalmic Association
Pittsburgh, Pennsylvania, 15219, United States
Location status: Recruiting
NCT Number: NCT07618364
The central hypothesis is that inflammation contributes to dry eye and that rinsing the palpebral conjunctiva, bulbar conjunctiva, and fornices will reduce the inflammatory burden on the ocular surface.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15219, United States
Location status: Recruiting
The objective is to determine whether irrigation of the bulbar conjunctiva, palpebral conjunctiva, conjunctival fornix, and the corneal surface reduces the inflammatory burden in patients with dry eye disease. The scientific premise is that inflammation contributes to the clinical symptoms of dry eye disease. By reducing the inflammatory mediators on the ocular surface, there may be a reduction in dry eye symptoms.
The primary endpoint is MMP-9 positivity. Secondary endpoints include CDES-Q, Ocular Itch Scale, and keratometry measurements.
The study population includes participants who have severe dry eye disease. The inclusion and exclusion criteria is described below. The goal is to recruit 150 patients, Including screen failures, a total of 250 participants will need to be screened for the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Irrigation via irrigating eyelid retractor
Time frame: 3 Hours
Tear MMP-9 levels will be assessed using a point-of-care diagnostic assay. Change from baseline to the specified follow-up visit will be analyzed.
Contact information is provided by the study sponsor or research team.
Rinsada
Industry
Acronym: RINSE-A
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03945071
Dry Eye, Dry Eye Syndromes
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT03302273
Blepharitis, Dry Eye
Amarillo, Texas, United States
View Trial DetailsNCT06903611
Dry Eye, Dry Eye Disease
View Trial DetailsNCT05481450
Dry Eye, Dry Eye Syndromes
Lutz, Florida, United States
View Trial Details